Literature DB >> 12475393

Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.

Philippe Soubeyran1, Ana Barac, Iwona Szymkiewicz, Ivan Dikic.   

Abstract

The mechanisms leading to the ubiquitination and degradation of the activated c-Abl kinase have not yet been identified. We found that the multi-adaptor protein ArgBP2 links c-Abl to the ubiquitin ligase Cbl. Phosphorylation of Cbl and ArgBP2 by c-Abl resulted in the stabilization of their interactions, thus facilitating Cbl-induced ubiquitination and subsequent degradation of c-Abl and ArgBP2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12475393      PMCID: PMC1223168          DOI: 10.1042/BJ20021539

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

Review 1.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways.

Authors:  J S Bonifacino; A M Weissman
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

2.  The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.

Authors:  G D Kruh; R Perego; T Miki; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway.

Authors:  Z Dai; R C Quackenbush; K D Courtney; M Grove; D Cortez; G W Reuther; A M Pendergast
Journal:  Genes Dev       Date:  1998-05-15       Impact factor: 11.361

4.  ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks.

Authors:  B Wang; E A Golemis; G D Kruh
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

Review 5.  The function of BCR/ABL and related proto-oncogenes.

Authors:  A Gotoh; H E Broxmeyer
Journal:  Curr Opin Hematol       Date:  1997-01       Impact factor: 3.284

6.  Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.

Authors:  Philippe Soubeyran; Katarzyna Kowanetz; Iwona Szymkiewicz; Wallace Y Langdon; Ivan Dikic
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

7.  The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.

Authors:  Annalisa Petrelli; Giorgio F Gilestro; Stefania Lanzardo; Paolo M Comoglio; Nicola Migone; Silvia Giordano
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

8.  The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

Authors:  Y Ben-Neriah; G Q Daley; A M Mes-Masson; O N Witte; D Baltimore
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 9.  CIN85/CMS family of adaptor molecules.

Authors:  Ivan Dikic
Journal:  FEBS Lett       Date:  2002-10-02       Impact factor: 4.124

10.  Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.

Authors:  C E Andoniou; C B Thien; W Y Langdon
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

View more
  33 in total

1.  CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.

Authors:  Katarzyna Kowanetz; Koraljka Husnjak; Daniela Höller; Marcin Kowanetz; Philippe Soubeyran; Dianne Hirsch; Mirko H H Schmidt; Kresimir Pavelic; Pietro De Camilli; Paul A Randazzo; Ivan Dikic
Journal:  Mol Biol Cell       Date:  2004-04-16       Impact factor: 4.138

2.  Cell biological characterization of a multidomain adaptor protein, ArgBP2, in epithelial NMuMG cells, and identification of a novel short isoform.

Authors:  Kana Murase; Hidenori Ito; Hiroyuki Kanoh; Kaori Sudo; Ikuko Iwamoto; Rika Morishita; Philippe Soubeyran; Mariko Seishima; Koh-Ichi Nagata
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

Review 3.  The sarcomeric Z-disc: a nodal point in signalling and disease.

Authors:  Derk Frank; Christian Kuhn; Hugo A Katus; Norbert Frey
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

4.  CAP interacts with cytoskeletal proteins and regulates adhesion-mediated ERK activation and motility.

Authors:  Mei Zhang; Jun Liu; Alan Cheng; Stephanie M Deyoung; Xiaowei Chen; Lisa H Dold; Alan R Saltiel
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

5.  PP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7.

Authors:  Maud Martin; Ilse Geudens; Jonathan Bruyr; Michael Potente; Anouk Bleuart; Marielle Lebrun; Nicolas Simonis; Christophe Deroanne; Jean-Claude Twizere; Philippe Soubeyran; Paul Peixoto; Denis Mottet; Veerle Janssens; Wolf-Karsten Hofmann; Filip Claes; Peter Carmeliet; Richard Kettmann; Holger Gerhardt; Franck Dequiedt
Journal:  EMBO J       Date:  2013-08-16       Impact factor: 11.598

Review 6.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

7.  Quantitative proteomic analysis of S-nitrosated proteins in diabetic mouse liver with ICAT switch method.

Authors:  Xu Zhang; Bo Huang; Xixi Zhou; Chang Chen
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

8.  SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

Authors:  Julie De Schutter; Aude Guillabert; Virginie Imbault; Chantal Degraef; Christophe Erneux; David Communi; Isabelle Pirson
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

Review 9.  Phosphoregulation of the WAVE regulatory complex and signal integration.

Authors:  Michelle C Mendoza
Journal:  Semin Cell Dev Biol       Date:  2013-01-24       Impact factor: 7.727

Review 10.  ArgBP2 and the SoHo family of adapter proteins in oncogenic diseases.

Authors:  Julie Roignot; Philippe Soubeyran
Journal:  Cell Adh Migr       Date:  2009-04-05       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.